Effect of Early Empagliflozin Initiation in Cardiogenic Shock.

NCT07450417 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

418

Enrollment

OTHER

Sponsor class

Conditions

Cardiogenic Shock

Interventions

DRUG: Patient in cardiogenic shock treated or not early with SGLT2 inhibitors.

Sponsor

Central Hospital, Nancy, France